BACKGROUND: Since the introduction of new recommendations for the treatment of latent tuberculosis infection (LTB1) disregarding age as a limitation, increasing numbers of older individuals are expected to undergo treatment with isoniazid for the preventi
Assessment of age-related isoniazid hepatotoxicity during treatment of latent tuberculosis infection.All Scholarly Works
Document TypeArticle, Peer-reviewed
Citation InformationCurr Med Res Opin. 2006 Jan;22(1):217-21.